Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,387.19
(
-0.29%
)
US TECH 100
28,152.40
(
-0.72%
)
Dow Jones
49,624.11
(
0.20%
)
Brent Oil
107.56
(
0.08%
)
Bitcoin
76,129.52
(
-1.65%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 67950

Wednesday, 10/29/2008 9:15:36 PM

Wednesday, October 29, 2008 9:15:36 PM

Post# of 257580
Funny… I was just mulling whether to add GNLB's NS5A inhibitor to my post on “HCV Most Likely to Succeed” because Kurt Graves mentioned NS5A as one of the mechanisms VRTX was interested in combining with Telaprevir.

I guess we now know why he said that.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today